A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants with X-Linked Retinitis Pigmentosa
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Beacon Therapeutics (USA) Inc.
Start Date
January 21, 2026
End Date
January 31, 2031
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Beacon Therapeutics (USA) Inc.
Start Date
January 21, 2026
End Date
January 31, 2031